Airway Therapeutics

  • About Us
  • Pipeline
  • BPD
  • Respiratory & Inflammatory Diseases
  • News
  • Contact

Airway Therapeutics featured on Worldwide Business with Kathy Ireland

September 10, 2017 By Airway Therapeutics

Filed Under: Media

Airway Therapeutics Closes $6.3M in Finance Round

March 17, 2017 By Airway Therapeutics

Financing furthers Company’s efforts to improve outcomes for very premature infants Cincinnati OH—March 6, 2017 Airway Therapeutics, a biotechnology company focused on developing new interventions for acute and chronic lung diseases, beginning with premature infants, has secured $6.3 million in bridge financing from new and existing investors. Cincinnati Children’s Hospital Medical Center, CincyTech and Queen …

Filed Under: News

Airways Therapeutics Featured on Bio International

June 27, 2016 By Airway Therapeutics

New Protein Replacement Therapy Makes Breathing Easier for Babies Hospitals are getting better at helping pre-term babies survive, but that help is having an unintended consequence. Each year over 160,000 pre-term babies in the US and Europe alone are at risk for developing bronchopulmonary dysplasia – or BPD. Of these pre-term babies, 49 percent will …

Filed Under: Media

Airway Therapeutics Featured on TechOhio

March 2, 2016 By Airway Therapeutics

Airway Therapeutics Helping Preemies’ Lungs Develop Written by Robert Leitch. When a baby is born prematurely, they often need mechanical ventilation and oxygenation — two medical tools that help keep preemies alive. However, these tools can also lead to inflammation and infection in the lung, which can result in bronchopulmonary dysplasia (BPD).  BPD is a lung …

Filed Under: Media

Airway Therapeutics in the Media

April 24, 2015 By Airway Therapeutics

The following link provides a summary of Airway Therapeutics coverage in the news media.

Filed Under: Media

Airway Therapeutics Raises $4.6 Million in Series A Funding

September 10, 2014 By Airway Therapeutics

Financing Follows FDA Orphan Designation for Startup Working to Improve Outcomes for Very Premature Infants (Cincinnati OH— September 10, 2014) Airway Therapeutics, a biotechnology company working to prevent a debilitating lung condition in extremely premature infants, has secured $4.6 million in Series A financing. CincyTech led the round, with participation from Cincinnati Children’s Hospital Medical …

Filed Under: News

New Company Formed to Take Cincinnati Children’s Lung Treatment Research to Premature Babies

June 3, 2011 By Airway Therapeutics

Airway Therapeutics LLC has been created to commercialize pulmonary therapy research developed at Cincinnati Children’s Hospital Medical Center and has received a $500,000 investment from CincyTech and Cincinnati Children’s Tomorrow Fund. The investments are part of a projected $1.2 million seed-stage funding round led by CincyTech. CincyTech and the Tomorrow Fund each invested $250,000 in …

Filed Under: News

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
logo

Airway Therapeutics, Inc

1200 Johnson Ferry Rd, Suite 300
Marietta, GA 30068

513.770.9630

  • Privacy

Sitemap

  • Home
  • About Us
  • Pipeline
  • BPD
  • Respiratory & Inflammatory Diseases
  • News
  • Contact
Copyright © 2015 Airway Therapeutics, Inc. All Rights Reserved.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.
Accept Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT
MENU
  • About Us
  • Pipeline
  • BPD
  • Respiratory & Inflammatory Diseases
  • News
  • Contact